Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma

被引:52
作者
Ren, Wei-hua [1 ]
Chang, Jiang [1 ,2 ]
Yan, Cheng-hu [1 ]
Qian, Xiao-min [1 ]
Long, Li-xia [1 ]
He, Bin [1 ]
Yuan, Xu-bo [1 ]
Kang, Chun-sheng [1 ,3 ]
Betbeder, Didier [2 ]
Sheng, Jing [1 ]
Pu, Pei-yu [3 ]
机构
[1] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China
[2] Univ Lille 2, EA 2689, Physiol Lab, IMPRT, F-59045 Lille, France
[3] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China
关键词
RECEPTOR-MEDIATED TRANSCYTOSIS; DRUG-DELIVERY; NANOPARTICLES; LIPOSOMES; BINDING; CARRIER;
D O I
10.1007/s10856-010-4106-5
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The aim of present study is to conceive a biodegradable poly(ethylene glycol)-polylactide (PEG-PLA) copolymer nanoparticle which can be surface biofunctionalized with ligands via biotin-avidin interactions and used as a potential drug delivery carrier targeting to brain glioma in vivo. For this aim, a new method was employed to synthesize biotinylated PEG-PLA copolymers, i.e., esterification of PEG with biotinyl chloride followed by copolymerization of hetero-biotinylated PEG with lactide. PEG-PLA nanoparticles bearing biotin groups on surface were prepared by nanoprecipitation technique and the functional protein transferrin (Tf) were coupled to the nanoparticles by taking advantage of the strong biotin-avidin complex formation. The flow cytometer measurement demonstrated the targeting ability of the nanoparticles to tumor cells in vitro, and the fluorescence microscopy observation of brain sections from C6 glioma tumor-bearing rat model gave the intuitive proof that Tf functionalized PEG-PLA nanoparticles could penetrate into tumor in vivo.
引用
收藏
页码:2673 / 2681
页数:9
相关论文
共 37 条
[1]   Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats [J].
Ambruosi, A ;
Khalansky, AS ;
Yamamoto, H ;
Gelperina, SE ;
Begley, DJ ;
Kreuter, J .
JOURNAL OF DRUG TARGETING, 2006, 14 (02) :97-105
[2]   Active targeting of brain tumors using nanocarriers [J].
Beduneau, Arnaud ;
Saulnier, Patrick ;
Benoit, Jean-Pierre .
BIOMATERIALS, 2007, 28 (33) :4947-4967
[3]   Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting [J].
Brigger, I ;
Morizet, J ;
Aubert, G ;
Chacun, H ;
Terrier-Lacombe, MJ ;
Couvreur, P ;
Vassal, G .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :928-936
[4]   Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery [J].
Calvo, P ;
Gouritin, B ;
Chacun, H ;
Desmaële, D ;
D'Angelo, J ;
Noel, JP ;
Georgin, D ;
Fattal, E ;
Andreux, JP ;
Couvreur, P .
PHARMACEUTICAL RESEARCH, 2001, 18 (08) :1157-1166
[5]   The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells [J].
Daniels, Tracy R. ;
Delgado, Tracie ;
Helguera, Gustavo ;
Penichet, Manuel L. .
CLINICAL IMMUNOLOGY, 2006, 121 (02) :159-176
[6]  
DAVIES M, 1981, J REPROD FERTIL, V63, P315
[7]   Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells [J].
Descamps, L ;
Dehouck, MP ;
Torpier, G ;
Cecchelli, R .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 270 (04) :H1149-H1158
[8]  
Eavarone DA, 2000, J BIOMED MATER RES, V51, P10, DOI 10.1002/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO
[9]  
2-R
[10]   HUMAN TRANSFERRIN RECEPTOR - EXPRESSION OF THE RECEPTOR IS ASSIGNED TO CHROMOSOME-3 [J].
ENNS, CA ;
SUOMALAINEN, HA ;
GEBHARDT, JE ;
SCHRODER, J ;
SUSSMAN, HH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (10) :3241-3245